• Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions
  Am J Hematol. 2009 Vol 84  (9):618 - 625 
• Definitions of the phenotypic manifestations of sickle cell disease
  Am J Hematol. 2010 Jan;85(1):1-3. 
• Discovering the genetics underlying foetal haemoglobin production in adults.
  Br J Haematol 2009; 145 (4): 455-467 

• Quantitation of Hepcidin
  Dr Sukhvinder S Bansal and Professor Robert C Hider, Pharmaceutical Sciences Division, King's College London, UK
  
• Matriptase 2, a new and unexpected player in the iron field.
  Dr Carole Beaumont, INSERM U773, Université Paris Diderot, site Bichat, 75018, Paris, France
  
• Can labile plasma iron (LPI) and labile cell iron (LCI) levels serve as early indicators of chelation efficacy in iron overload?
  Ioav Cabantchik¹, Eitan Fibach² and William Breuer¹,
  ¹Department of Biological Chemistry, Institute of Life Sciences, Hebrew University of Jerusalem, Israel 91904 and ²Department of Hematology, Hadassah - Hebrew University Medical Center, Ein Kerem, Jerusalem, Israel.
  

• Nature Genetics
• Journal of Clinical Investigation
• Blood
• Haematologica
• British Journal of Haematology
• Annals of Hematology
• American Journal of Hematology
• Hemoglobin

Current clinical guidelines.

• Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders
  Italian Society of Hematology
  Haematologica May 2008; 93 (5): 741-52
• Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.
  The General Haematology Task Force of the British Committee for Standards in Haematology.
  British Journal of Haematology 2005: 130; 174-95.
• Guidelines for the diagnosis and management of hereditary spherocytosis
  BCSH
  British Journal of Haematology 2004; 126: 455 -474.

Slide atlas

Slide of the week:

Calendar
Journals
Profiles